Journal Article10.1080/09537104.2020.1869928
Acquired hemophilia A and delta storage pool deficiency in a patient with indolent non-Hodgkin lymphoma.
Raffaella Rossio,Ramona Cassin,Anna Lecchi,Silvia La Marca,Eti A. Femia,Cristina Novembrino,Simona Maria Siboni,Alessandro Noto,Gianluigi Reda,Flora Peyvandi,Flora Peyvandi +10 more
1
TL;DR: B-cell lymphoproliferative diseases may be associated with acquired hemostasis disorders, such as acquired hemophilia A (AHA) caused by autoantibodies that neutralize factor VIII activity, and δ-st...
read more
Abstract: B-cell lymphoproliferative diseases may be associated with acquired hemostasis disorders, such as acquired hemophilia A (AHA) caused by autoantibodies that neutralize factor VIII activity, and δ-st...
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
References
Recommendations for the standardization of light transmission aggregometry : a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH
Marco Cattaneo,Chiara Cerletti,Paul Harrison,Catherine P.M. Hayward,Dermot Kenny,Diane J. Nugent,Paquita Nurden,A. K. Rao,Alvin H. Schmaier,Steve P. Watson,Federico Lussana,Mariateresa Pugliano,Alan D. Michelson +12 more
TL;DR: The Platelet Physiology Subcommittee of the Scientific and Standardization Committee (SSC) of the International Society on Thrombosis and Haemostasis formed a working party of experts with the aim of producing a series of consensus recommendations for standardizing LTA, which formed the basis of a consensus document, which is the subject of the present report.
509
Acquired hemophilia A: Updated review of evidence and treatment guidance.
Rebecca Kruse-Jarres,Christine L. Kempton,Francesco Baudo,Peter William Collins,Paul Knoebl,Cindy A. Leissinger,Andreas Tiede,Craig M. Kessler +7 more
TL;DR: Acquired hemophilia A is a rare disease resulting from autoantibodies against endogenous factor VIII (FVIII) that leads to bleeding, which is often spontaneous and severe.
325
Consensus recommendations for the diagnosis and treatment of acquired hemophilia A.
Peter William Collins,Francesco Baudo,Angela Huth-Kühne,Jørgen Ingerslev,Craig M. Kessler,Maria Eva Mingot Castellano,Midori Shima,Jean St-Louis,Hervé Levesque +8 more
TL;DR: Recommendations aim to increase awareness of this disorder among clinicians in a wide range of specialties and provide practical advice on diagnosis and treatment of acquired hemophilia A.
Efficacy and safety of OBI‐1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A
Rebecca Kruse-Jarres,Jean St-Louis,Anne Greist,Amy D. Shapiro,Hedy Smith,Pratima Chowdary,A. Drebes,Edward D. Gomperts,C. Bourgeois,Min Mo,Aaron Novack,Heinrich D. Farin,Bruce M. Ewenstein +12 more
TL;DR: The ability to safely and effectively titrate dosing based on FVIII activity levels in this study demonstrates that OBI‐1 fulfils the unmet medical need to monitor the key coagulation parameter in AHA patients.
176
Acquired hemophilia A: a review of recent data and new therapeutic options
Massimo Franchini,Stefania Vaglio,Giuseppe Marano,Carlo Mengoli,Sara Gentili,Simonetta Pupella,Giancarlo M. Liumbruno +6 more
TL;DR: The optimal management of Acquired hemophilia A should be multidisciplinary and requires a close collaboration between physicians from various specialties.
106